KR840002840A - 1,1-알칸디올 디카복실레이트에 의해 결합된 항균제의 제조방법 - Google Patents
1,1-알칸디올 디카복실레이트에 의해 결합된 항균제의 제조방법 Download PDFInfo
- Publication number
- KR840002840A KR840002840A KR1019820005730A KR820005730A KR840002840A KR 840002840 A KR840002840 A KR 840002840A KR 1019820005730 A KR1019820005730 A KR 1019820005730A KR 820005730 A KR820005730 A KR 820005730A KR 840002840 A KR840002840 A KR 840002840A
- Authority
- KR
- South Korea
- Prior art keywords
- hydrogen
- compound
- formula
- chlorine
- alkyl
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title claims 2
- 239000004599 antimicrobial Substances 0.000 title 1
- 229910052739 hydrogen Inorganic materials 0.000 claims 19
- 239000001257 hydrogen Substances 0.000 claims 19
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 14
- 150000001875 compounds Chemical class 0.000 claims 8
- 238000000034 method Methods 0.000 claims 8
- 239000000460 chlorine Substances 0.000 claims 6
- 229910052801 chlorine Inorganic materials 0.000 claims 5
- 150000002431 hydrogen Chemical class 0.000 claims 5
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims 4
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims 4
- -1 azido, benzyloxycarbonylamino, 4-nitrobenzyloxycarbonylamino Chemical group 0.000 claims 4
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims 4
- 229910052794 bromium Inorganic materials 0.000 claims 4
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical group CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims 3
- 125000000217 alkyl group Chemical group 0.000 claims 3
- 239000011630 iodine Substances 0.000 claims 3
- 229910052740 iodine Inorganic materials 0.000 claims 3
- DZLFLBLQUQXARW-UHFFFAOYSA-N tetrabutylammonium Chemical compound CCCC[N+](CCCC)(CCCC)CCCC DZLFLBLQUQXARW-UHFFFAOYSA-N 0.000 claims 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims 2
- UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 claims 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims 2
- 125000002947 alkylene group Chemical group 0.000 claims 2
- 239000011591 potassium Substances 0.000 claims 2
- 229910052700 potassium Inorganic materials 0.000 claims 2
- 239000011734 sodium Substances 0.000 claims 2
- 229910052708 sodium Inorganic materials 0.000 claims 2
- 239000002904 solvent Substances 0.000 claims 2
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 125000001118 alkylidene group Chemical group 0.000 claims 1
- 125000003277 amino group Chemical group 0.000 claims 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 1
- 150000007942 carboxylates Chemical class 0.000 claims 1
- 238000009903 catalytic hydrogenation reaction Methods 0.000 claims 1
- 125000002091 cationic group Chemical group 0.000 claims 1
- 150000001768 cations Chemical class 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 claims 1
- 125000001309 chloro group Chemical group Cl* 0.000 claims 1
- 125000002993 cycloalkylene group Chemical group 0.000 claims 1
- 229910052731 fluorine Inorganic materials 0.000 claims 1
- 239000011737 fluorine Substances 0.000 claims 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 1
- 125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 claims 1
- 239000003495 polar organic solvent Substances 0.000 claims 1
- 238000009938 salting Methods 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D499/21—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a nitrogen atom directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D499/28—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a nitrogen atom directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with modified 2-carboxyl group
- C07D499/32—Esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Abstract
내용 없음
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (10)
- a) PCOOM과 다음 일반식(A)의 화합물, 또는 b) PCOOCH(R3)X와 다음 일반식(B)의 화합물, 또는 c) BCOOCH(R3)X와 다음 일반식(C)의 화합물, 또는 d) BCOOM과 다음 일반식(D)의 화합물을 극성 유기용매의 존재하에서 접촉시키고, p가 아지도, 벤질옥시카보닐아미노, 4-니트로벤질옥시카보닐아미노 또는 1-메틸-2-메톡시카보닐비닐아미노그룹중에서 선택된 Q1그룹을 함유하는 경우에는 상술한 그룹을 아미노그룹으로 임의로 전환시킴을 특징으로 하여, 다음 일반식(Ⅰ)의 화합물 또는 그의 약학제적으로 무독한 양이온성염 또는 산부가염을 제조하는 방법.상기식에서, A는 (C1내지 C12)알킬렌, (C1내지 C12)-알킬리덴, (C3내지 C7)사이클로알킬렌, 페닐렌, 나프탈렌,페닐 또는 카복시에 의해 치환된 상술한 알킬렌 또는 알킬리덴이며; R3는 수소 또는 (C1내지 C3)알킬이고; n은 0 또는 1이며; R 및 R1은 다르며, R은 P 또는 B이고, n이 0이면, R1은 수소, (C1내지 C4)알킬, 벤질, CH(R3)Cl, CH(R3)I 또는 테트라부틸암모늄이며, n이 1이면, R1은 P 또는 B이고; P는이며;[여기에서, R2는 수소Q1은 수소, NH2,N3, 벤질옥시카보닐아미노, 4-니트로벤질옥시카보닐아미노 또는 1-메틸-2-메톡시카보닐아미노이며; R4는 수소, OH, (C2내지 C7)-알카노일옥시(C2내지 C7)-알콕시카보닐옥시 또는 R5C6H4COO이고; R5는 수소, (C1내지 C4)알킬, (C1내지 C4)-알콕시, 불소, 염소, 브롬 또는 CN이다]B는이고; [여기에서, Y가 수소이면, X1은 수소, CH2OH 또는 CH(R8)NH2[여기에서 R8은 수소 또는 CH3이다]이며; Y가 염소 또는 CH3COO이면, X1은 수소이고; X3는 염소, 브롬 또는 요오드이다]. M은 카복실레이트 염형성 양이온이며; X는 이탈그룹이다.
- 제1항에 있어서, 상술한 접촉반응을 0 내지 80℃의 온도에서 수행하며, 상술한 용매가 N,N-디메틸포름아미드, 에틸아세테이트, 디클로로메탄 또는 아세톤인 방법.
- 제2항에 있어서, 상술한 온도가 25 내지 50℃인 방법.
- 제1항의 a) 또는 b)에 있어서, n이 0이며, R1이 수소,(C1내지 C4)-알킬, 나트륨, 칼륨 또는 테트라부틸암모늄이고, R3가 수소인 방법.
- 제1항의 c) 또는 d)에 있어서, n이 0이며, R1이 수소,(C1내지 C4)-알킬, 나트륨, 칼륨 또는 테트라부틸암모늄이고, R3가 수소인 방법.
- 제1항에 있어서, n이 1이며, R 및 R1중의 하나가 B이고, 다른 하나가 P이며, R3가 수소인 방법.
- 제1항에 있어서, R2가인 방법.
- 다음 일반식(XVI)의 화합물을 0 내지 60℃에서 용매의 존재하에 촉매적 수소화시킴을 특징으로 하여, 다음 일반식(VⅢ)의 화합물을 제조하는 방법.상기식에서, A,R3및 R4는 제1항에서 정의한 바와 같고; Q2는 아지도, 벤질옥시카보닐아미노 또는P-니트로벤질옥시카보닐아미노이며; R10은 수소, 염소, 브롬 또는 요오드이고; R11은 염소, 브롬 또는 요오드이다.
- 제7항 또는 8항에 있어서, R3가 수소이며, R4가 수소 또는 OH인 방법.
- 제9항에 있어서, R4가 수소인 방법.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US33402281A | 1981-12-22 | 1981-12-22 | |
US334022 | 1981-12-22 | ||
US334,022 | 1981-12-22 | ||
US06/429,915 US4457924A (en) | 1981-12-22 | 1982-09-30 | 1,1-Alkanediol dicarboxylate linked antibacterial agents |
US429915 | 1982-09-30 | ||
US429,915 | 1982-09-30 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR840002840A true KR840002840A (ko) | 1984-07-21 |
KR860001370B1 KR860001370B1 (ko) | 1986-09-17 |
Family
ID=26989011
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR8205730A KR860001370B1 (ko) | 1981-12-22 | 1982-12-21 | 1,1-알칸디올 디카복실레이트에 의해 결합된 항균제의 제조방법 |
Country Status (25)
Country | Link |
---|---|
US (1) | US4457924A (ko) |
EP (1) | EP0083484B1 (ko) |
JP (1) | JPH02270881A (ko) |
KR (1) | KR860001370B1 (ko) |
AU (1) | AU537214B2 (ko) |
BG (4) | BG50162A3 (ko) |
CA (1) | CA1213582A (ko) |
DD (1) | DD207379A5 (ko) |
DE (1) | DE3269267D1 (ko) |
DK (3) | DK565482A (ko) |
ES (3) | ES8402310A1 (ko) |
FI (1) | FI80039C (ko) |
GR (1) | GR77066B (ko) |
GT (1) | GT198200058A (ko) |
HU (1) | HU187737B (ko) |
IE (1) | IE54333B1 (ko) |
IL (1) | IL67530A (ko) |
NO (1) | NO824305L (ko) |
NZ (1) | NZ202670A (ko) |
PH (1) | PH18311A (ko) |
PL (3) | PL141306B1 (ko) |
PT (1) | PT76012B (ko) |
RO (2) | RO87709A (ko) |
SU (1) | SU1405704A3 (ko) |
YU (2) | YU43111B (ko) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4675186A (en) | 1985-04-18 | 1987-06-23 | Pfizer Inc. | 6-(1-acyl-1-hydroxymethyl)penicillanic acid derivatives |
LU87821A1 (fr) * | 1990-10-12 | 1992-05-25 | Cird Galderma | Composes bi-aromatiques,et leur utilisation en medecine humaine et veterinaire et en cosmetique |
ATE115114T1 (de) * | 1991-03-11 | 1994-12-15 | Schweizerhall Saeurefab | Verfahren zur herstellung von chlorierten carbonsäureestern. |
EP0508943B1 (de) * | 1991-03-11 | 1994-12-14 | Säurefabrik Schweizerhall | Verfahren zur Herstellung von halogenierten Carbonsäureestern |
WO2004035540A1 (ja) * | 2002-10-18 | 2004-04-29 | Meiji Seika Kaisha, Ltd. | マロン酸モノエステルおよびその製造方法 |
KR101746250B1 (ko) * | 2009-12-01 | 2017-06-12 | 스미또모 가가꾸 가부시키가이샤 | 시클로알칸디카르복실산 모노에스테르의 제조 방법 |
US7973194B1 (en) | 2010-03-18 | 2011-07-05 | Eastman Chemical Company | High solvating cyclohexane dicarboxylate diesters plasticizers |
CN115385934A (zh) * | 2022-10-26 | 2022-11-25 | 北京纳百生物科技有限公司 | 一种舒巴坦半抗原及其合成方法和应用 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2985648A (en) * | 1958-10-06 | 1961-05-23 | Doyle Frank Peter | Alpha-aminobenzylpenicillins |
NL299897A (ko) * | 1962-11-02 | |||
US3520876A (en) * | 1967-11-01 | 1970-07-21 | American Home Prod | Process for the preparation of 6-(alpha-aminoacylamino)penicillanic acids |
ES436565A1 (es) * | 1974-06-05 | 1977-04-01 | Bristol Myers Co | Un procedimiento para la preparacion de acidos acetamidope- nicilanicos. |
FR2290443A1 (fr) * | 1974-11-06 | 1976-06-04 | Aries Robert | Nouveaux esters bispenicillaniques |
FR2309570A1 (fr) * | 1975-04-29 | 1976-11-26 | Aries Robert | Derives polymeriques des penicillines et cephalosporines |
GB1569421A (en) * | 1976-06-11 | 1980-06-18 | Beecham Group Ltd | Penicillin compositions |
US4234579A (en) * | 1977-06-07 | 1980-11-18 | Pfizer Inc. | Penicillanic acid 1,1-dioxides as β-lactamase inhibitors |
IE49881B1 (en) * | 1979-02-13 | 1986-01-08 | Leo Pharm Prod Ltd | B-lactam intermediates |
US4244951A (en) * | 1979-05-16 | 1981-01-13 | Pfizer Inc. | Bis-esters of methanediol with penicillins and penicillanic acid 1,1-dioxide |
US4309347A (en) * | 1979-05-16 | 1982-01-05 | Pfizer Inc. | Penicillanoyloxymethyl penicillanate 1,1,1',1'-tetraoxide |
-
1982
- 1982-09-30 US US06/429,915 patent/US4457924A/en not_active Expired - Lifetime
- 1982-12-01 NZ NZ202670A patent/NZ202670A/en unknown
- 1982-12-01 BG BG89819/89A patent/BG50162A3/xx unknown
- 1982-12-01 BG BG89818/89A patent/BG50161A3/xx unknown
- 1982-12-01 BG BG89817/89A patent/BG50160A3/xx unknown
- 1982-12-14 DE DE8282306683T patent/DE3269267D1/de not_active Expired
- 1982-12-14 EP EP82306683A patent/EP0083484B1/en not_active Expired
- 1982-12-17 GT GT198200058A patent/GT198200058A/es unknown
- 1982-12-20 RO RO82113244A patent/RO87709A/ro unknown
- 1982-12-20 RO RO109396A patent/RO84911B/ro unknown
- 1982-12-21 IE IE3034/82A patent/IE54333B1/en not_active IP Right Cessation
- 1982-12-21 PL PL1982239651A patent/PL141306B1/pl unknown
- 1982-12-21 ES ES518425A patent/ES8402310A1/es not_active Expired
- 1982-12-21 BG BG58979A patent/BG48694A3/xx unknown
- 1982-12-21 PL PL1982248637A patent/PL140291B1/pl unknown
- 1982-12-21 NO NO824305A patent/NO824305L/no unknown
- 1982-12-21 DD DD82246325A patent/DD207379A5/de not_active IP Right Cessation
- 1982-12-21 YU YU2844/82A patent/YU43111B/xx unknown
- 1982-12-21 DK DK565482A patent/DK565482A/da unknown
- 1982-12-21 HU HU824105A patent/HU187737B/hu not_active IP Right Cessation
- 1982-12-21 PH PH28306A patent/PH18311A/en unknown
- 1982-12-21 PT PT76012A patent/PT76012B/pt unknown
- 1982-12-21 AU AU91721/82A patent/AU537214B2/en not_active Ceased
- 1982-12-21 SU SU823529507A patent/SU1405704A3/ru active
- 1982-12-21 IL IL67530A patent/IL67530A/xx unknown
- 1982-12-21 GR GR70128A patent/GR77066B/el unknown
- 1982-12-21 FI FI824409A patent/FI80039C/fi not_active IP Right Cessation
- 1982-12-21 CA CA000418192A patent/CA1213582A/en not_active Expired
- 1982-12-21 PL PL1982256903A patent/PL145927B1/pl unknown
- 1982-12-21 KR KR8205730A patent/KR860001370B1/ko active
-
1983
- 1983-08-11 ES ES524894A patent/ES8503001A1/es not_active Expired
- 1983-08-11 ES ES524895A patent/ES8530002A1/es not_active Expired
-
1984
- 1984-10-25 YU YU1830/84A patent/YU43992B/xx unknown
-
1990
- 1990-02-14 JP JP2033601A patent/JPH02270881A/ja active Pending
-
1992
- 1992-05-26 DK DK92690A patent/DK69092D0/da unknown
- 1992-05-26 DK DK92691A patent/DK69192D0/da not_active Application Discontinuation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR850008484A (ko) | 광학적 활성 알파-아릴알카노산의 제조방법 | |
KR880000433A (ko) | 이미다조피리딘 및 중간체 화합물의 제조방법 | |
KR860003215A (ko) | 4-페닐피롤 유도체의 제조방법 | |
KR840005450A (ko) | 말론산에스테르의 이성화 방법 | |
KR830001947A (ko) | 화합물의 제조방법 | |
KR840002840A (ko) | 1,1-알칸디올 디카복실레이트에 의해 결합된 항균제의 제조방법 | |
KR860001117A (ko) | 2-치환된-1,3-프로필리덴디포스폰산염 유도체의 제법 | |
KR840000463A (ko) | 광학적으로 활성인 1-방향족 그룹으로 치환된-1- 알카논의 제조방법 | |
KR850001224A (ko) | 아미노 메틸 포스폰기를 함유하는 술폰이미드계 제초제의 제조방법 | |
KR910006239A (ko) | 4급화된 이미다졸린 직물 컨디쇼닝 화합물을 제조하는 방법 | |
KR840006482A (ko) | 디히드로피라졸로 [3,4-b]피리딘 유도체의 제조방법 | |
KR850002459A (ko) | 디히드록시벤즈아미드 유도체 및 그 제조방법 | |
KR890008090A (ko) | 퍼옥시카르복실릭 아미노 유도체 | |
KR840004750A (ko) | 피라졸로피리딘 화합물의 제조방법 | |
KR840000493A (ko) | 피리딘으로부터 유도된 아미드 및 에스테르기를 포함하는 제초제의 제조방법 | |
KR840006487A (ko) | 세팔로스포린의 제조방법 | |
KR860004035A (ko) | N-아릴 트리아졸의 제조방법 | |
KR840001968A (ko) | 4-페닐퀴나졸린 유도체의 제조방법 | |
KR840005139A (ko) | 피라졸로피리딘 유도체의 제조방법 | |
KR840002406A (ko) | 3위치가 티오메틸 복소환 그룹에 의해 치환된 신규의 세팔로스포린유도체의 제조방법세 | |
KR920004397A (ko) | 1-옥사-3,8-디아자-4-옥소스피로[4,5]데칸 화합물의 제조방법. | |
KR840008647A (ko) | 대칭 1,4-디하이드로피리딘디카복실 에스테르의 제조방법 | |
SU827608A1 (ru) | Электролит дл осаждени покрытийиз СплАВА циНК-НиКЕль | |
KR830001943A (ko) | 페니실린과 세팔로스포린 이미노할라이드의 제조방법 | |
KR850007428A (ko) | 세파로스포린 화합물의 제조방법 |